Sandy Cove Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
ATO
Sandy Cove Advisors's MRK Position: Q2 2026 in Review
Sandy Cove Advisors increased its Merck (MRK) stake by 7.3% in Q2 2026, buying an estimated $18.4K and bringing the position to 2,309 shares worth $297K. The position accounts for 0.07% of the portfolio, ranked #123.
Sandy Cove Advisors first reported a position in MRK in Q4 2021 and has held it in 16 quarters since. The position peaked at $594K in Q2 2023. 1,553 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Sandy Cove Advisors held 2,309 shares of Merck worth $297K as of Q2 2026.
- Sandy Cove Advisors bought 157 Merck shares in Q2 2026, an estimated $18.4K.
- Merck made up 0.07% of Sandy Cove Advisors's portfolio in Q2 2026, its #123 holding.
- Sandy Cove Advisors first reported a position in Merck in Q4 2021 and has held it in 16 quarters since.
- Sandy Cove Advisors's Merck position peaked at $594K in Q2 2023.
- 1,553 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Sandy Cove Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.